Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 606-870-3 | CAS number: 219715-34-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 6 - February 11, 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Conducted to GLP and recognised guidelines.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Dow Protocol No: P320.UDP DOW
- Deviations:
- not applicable
- GLP compliance:
- yes
- Test type:
- up-and-down procedure
- Limit test:
- no
Test material
- Reference substance name:
- 2-methoxy-4-(trifluoromethyl)pyridine
- EC Number:
- 606-870-3
- Cas Number:
- 219715-34-1
- Molecular formula:
- C7H6F3NO
- IUPAC Name:
- 2-methoxy-4-(trifluoromethyl)pyridine
- Details on test material:
- - Name of test material (as cited in study report): M-TMP
- Physical state: colourless liquid
- Analytical purity: 99.7%
- Lot/batch No.: 041206-7D
- Expiration date of the lot/batch: n/a
- Stability under test conditions: Test substance was expected to be stable for the duration of testing.
- Storage condition of test material: room temperature
- pH: 6-7 (by wetted pH paper)
- Solubility: Soluble in methanol, ethanol, and acetone.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Received from Charles River Laboratories, Raleigh, NC on December 7 and 28, 2004 and January 11, 2005.
- Age at study initiation: Young adult (9-12 weeks)
- Weight at study initiation: 1128-144 grams at experimental start.
- Fasting period before study: fasted overnight
- Housing: The animals were singly housed in suspended stainless steel caging with mesh floors which conform to the size recommendations in the most recent Guide for the Care and Use of Labora aty Animals DHEW (NIH), Litter paper was placed beneath the cage and was changed at least three times per week.
- Diet (e.g. ad libitum): Purina Certified Rodent Diet (PAR 115002)
- Water (e.g. ad libitum): Filtered tap water was supplied ad-libitum by an automatic water dispensing system.
- Acclimation period: 8-31 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-24°C
- Humidity (%): 30-66%
- Photoperiod (hrs dark / hrs light): 12-hour light/dark cycle
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- DOSAGE PREPARATION:
Individual doses were calculated based on the initial body weights, taking into account the specific gravity (determined by PSL) of the test substance.
The test substance was administered using a stainless steel ball-tipped gavage needle attached to an appropriate syringe. Following administration, each animal was returned to its designated cage. Feed was replaced immediately after dosing. - Doses:
- Individual animals were dosed as follows:
Main Test
Dosing Sequence Animal No. Dose Level (mg/kg) Short-Term Outcome Long-Term Outcome
1 9995 175 S S
2 108 550 S S
3 123 1,750 S S
4 134 5000 D D
5 326 1,750 D D
6 471 550 S S
7 478 1,750 D D
8 568 550 S S
9 628 1,750 D D
S - Survival D - Death
The test substance was administered in sequence to the animals as described above, The decision to proceed with the next animal was based on the survival of the previous animal in the short-term period following dosing. Dose progressions and stopping criteria were determined using A statistical program. - No. of animals per sex per dose:
- A total of 9 Female, nulliparous and non-pregnant rats were used in this study. (175 mg/kg = 1 animal; 550 mg/kg = 3 animals, 1750 mg/kg = 4 animals, 5000 mg/kg = 1 animal)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed for mortality, signs of gross toxicity, and behavioral changes for the first several hours post-dosing and at least once daily thereafter for up to 14 days after dosing. Observations included gross evaluation of skin and fur, eyes and mucous membranes, respiratory, circulatory, autonomic and central nervous systems, somatomotor activity and behavior pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhea, and coma.
Individual body weights of the animals were recorded prior to test substance administration (initial) and again on Days 7 and 14 (termination).
- Necropsy of survivors performed: yes
- Other examinations performed: Surviving rats were euthanized via CO2 inhalation at the end of the 14-day observation period. Gross necropsies were performed on all decedents and euthanized animals. The external surface of the body and all orifices, tissues, and organs of the thoracic and abdominal cavities were examined. - Statistics:
- The Acute Oral Toxicity (Guideline 425) Statistical Program (Weststat, version 1.0, May 2001) was used for all data analyses including: dose progression selections, stopping criteria determinations and/or LD50 and confidence limit calcuations.
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 750 mg/kg bw
- Based on:
- act. ingr.
- 95% CL:
- 651.9 - 2 690
- Mortality:
- In the 175 & 550 mg/kg Dose Levels, all animals survived exposure to the test substance.
In the 1,750 mg/kg Dose Level, three of four animals died within three days of test substance administration.
In the 5,000 mg/kg Dose Level, this animal died within one day of test substance administration. - Clinical signs:
- other: In the 175 & 550 mg/kg Dose Levels, there were no signs of gross toxicity, adverse clinical signs, or abnormal behavior. In the 1,750 mg/kg Dose Level, adverse clinical signs noted prior to death included abnormal posture, hypoactivity, reduced fecal vol
- Gross pathology:
- In the 175 & 550 mg/kg Dose Levels, no gross abnormalities were noted for this animal when necropsied at the conclusion of the 14-day observation period,
In the 1,750 mg/kg Dose Level, gross necropsy of the decedents revealed discoloration of the intestines. No gross abnormalities were noted for any of the surviving animals when necropsied at the conclusion of the 14-day observation period.
In the 5,000 mg/kg Dose Level, gross necropsy of the decedent revealed discoloration of the intestines.
Any other information on results incl. tables
Individual body weights, closes, and mortalities are presented in Table 1. Individual cage-side and necropsy observations are presented in Tables 2 and 3, respectively.
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study, the acute oral LD50 of M-TMP was estimated to be 1,750 mg/kg of body weight in female rats with an approximate 95% confidence interval of 651.9 mg/kg (lower) to 2,690 mg/kg (upper).
- Executive summary:
An acute oral toxicity test (Up and Down Procedure) was conducted with rats to determine the potential for M-TMP to produce toxicity from a single dose via the oral route. Under the conditions of this study, the acute oral LD50 of the test substance was estimated to be 1,750 mg/kg of body weight in female rats with an approximate 95% confidence interval of 651.9 mg/kg (lower) to 2,690 mg/kg (upper).
A Main Test was conducted using a starting dose level of 175 mg/kg which was administered to one healthy female rat by oral gavage. Following the up and down procedure, eight additional animals were dosed at levels of 550, 1,750, or 5,000 mg/kg. Females were selected for the test because they are frequently more sensitive to the toxicity of test compounds than males. All animals were observed for mortality, signs of gross toxicity, and behavioral changes at least once daily for up to 14 days after dosing. Body weights were recorded prior to administration, on Days 7 and 14 (termination). Necropsies were performed on all animals.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.